A Phase I Study of Talimogene Laherparepvec (Talimogene Laherparepvec) With Neoadjuvant Chemotherapy and Radiation in Adenocarcinoma of the Rectum
Phase of Trial: Phase I
Latest Information Update: 16 Jul 2018
At a glance
- Drugs Talimogene laherparepvec (Primary) ; Capecitabine; Fluorouracil; Oxaliplatin
- Indications Adenocarcinoma; Rectal cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 12 Jul 2018 Status changed from suspended to recruiting.
- 27 Apr 2018 Status changed from recruiting to suspended as per CTEP Action Letter.